- NeOnc Technologies (NASDAQ:NTHI) received board approval for its planned $50M equity deal with Quazar Investment.
- The non-binding term sheet includes a $25/share capital raise, with 70% for stock purchase and 30% for MENA clinical expansion.
- The deal aims to fund trials and infrastructure in the UAE and broader MENA region.
- Remaining steps include forming NuroMENA and NuroCure, sublicensing key assets, and finalizing agreements and a two-year plan.
- NeOnc has 120 days to complete all conditions for the transaction to close.
- NTHI shares up nearly 62% premarket on Thursday.
- Source: Press release
NeOnc board approves step toward $50M Quazar deal, MENA expansion; shares up 62%

Related
Mali military helicopter airlifts gold from Barrick's Loulo-...
17 minutes ago
0
The housing market is flashing warning signs about high mort...
18 minutes ago
0
Bitcoin reaches all-time highs as it surges beyond $113,000
25 minutes ago
0
Tech Voices: Musk on Grok, Tesla; UK, France invest in Starl...
25 minutes ago
0
Healthcare Services Group dips over 8% after Genesis files f...
35 minutes ago
0
Pure Cycle outlines $31M FY2025 revenue and 100-unit rental ...
42 minutes ago
0
Fed Governor Waller favors cutting interest rates in July an...
45 minutes ago
0
Car rental rally: Hertz and Avis soar again as shorts get pr...
53 minutes ago
0
Delta Air Lines' upbeat outlook fuels travel rally
1 hour ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved